Healx

The company utilizes artificial intelligence and frontier technologies to identify novel drug-disease relationships by redeveloping, combining, and enhancing known compounds. Its platform aims to de-risk the drug discovery process and scale a pipeline of therapies specifically for the 10,000 rare diseases that currently lack effective treatments. The firm collaborates with patient groups and strategic partners to move these treatments from digital prediction to clinical application.